Last $0.32 USD
Change Today 0.00 / 0.00%
Volume 0.0
PARD On Other Exchanges
Symbol
Exchange
Stuttgart
As of 8:10 PM 04/11/14 All times are local (Market data is delayed by at least 15 minutes).

poniard pharmaceuticals inc (PARD) Snapshot

Open
$0.32
Previous Close
$0.32
Day High
$0.32
Day Low
$0.32
52 Week High
01/6/14 - $0.56
52 Week Low
06/10/13 - $0.20
Market Cap
479.8K
Average Volume 10 Days
235.0
EPS TTM
$-11.20
Shares Outstanding
1.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PONIARD PHARMACEUTICALS INC (PARD)

Related News

No related news articles were found.

poniard pharmaceuticals inc (PARD) Related Businessweek News

No Related Businessweek News Found

poniard pharmaceuticals inc (PARD) Details

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic colorectal cancer and castration-resistant prostate cancer; and a Phase I study evaluating an oral formulation of picoplatin in solid tumors. The company was formerly known as NeoRx Corporation and changed its name to Poniard Pharmaceuticals, Inc. in September 2006. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington.

7 Employees
Last Reported Date: 10/12/11
Founded in 1984

poniard pharmaceuticals inc (PARD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PARD:US $0.32 USD 0.00

PARD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PARD.
View Industry Companies
 

Industry Analysis

PARD

Industry Average

Valuation PARD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PONIARD PHARMACEUTICALS INC, please visit www.poniard.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.